2024
Criteria for PAVM Reintervention
Fish A, Knight E, Henderson K, Pollak J, Schlachter T. Criteria for PAVM Reintervention. Journal Of Clinical Medicine 2024, 13: 6104. PMID: 39458055, PMCID: PMC11508501, DOI: 10.3390/jcm13206104.Peer-Reviewed Original ResearchParadoxical embolismRetrospective review of patientsReview of patientsModern embolization techniquesRetrospective reviewEmbolization techniquesReinterventionScreening intervalEmbolizationLifetime prevalence ratesPatientsRecurrencePAVMsHemoptysisSpontaneous eventsPrevalence ratesCenters of excellenceReperfusionCriteria
2017
Clinical Significance of Pulmonary Arteriovenous Malformation Reperfusion
Kaufman C, Henderson K, Pollak J. Clinical Significance of Pulmonary Arteriovenous Malformation Reperfusion. Journal Of Clinical Interventional Radiology ISVIR 2017, 01: 156-160. DOI: 10.1055/s-0037-1604096.Peer-Reviewed Original ResearchSymptomatic patientsClinical significancePulmonary arteriovenous malformation (PAVM) embolizationTime of diagnosisPulmonary arteriovenous malformationsTime of embolizationTime of presentationArteriovenous malformation embolizationHHT CenterInitial embolizationMedical comorbiditiesRetrospective reviewClinical historySevere manifestationsPAVM embolizationArteriovenous malformationsInitial procedureEmbolization proceduresTreatment periodEmbolizationPatientsMild manifestationsReperfusionSymptomsPAVMs
2004
Pulmonary arteriovenous malformations in children: Outcomes of transcatheter embolotherapy
Faughnan ME, Thabet A, Mei-Zahav M, Colombo M, MacLusky I, Hyland RH, Pugash RA, Chait P, Henderson KJ, White RI. Pulmonary arteriovenous malformations in children: Outcomes of transcatheter embolotherapy. The Journal Of Pediatrics 2004, 145: 826-831. PMID: 15580209, DOI: 10.1016/j.jpeds.2004.08.046.Peer-Reviewed Original ResearchConceptsPulmonary arteriovenous malformationsTranscatheter embolotherapyArteriovenous malformationsPleuritic chest painLife-threatening complicationsLong-term complicationsChest painNeurologic complicationsComplication rateMean ageComplicationsPatientsFurther complicationsEmbolotherapyAdult ratesChildrenMalformationsOutcomesHemoptysisCyanosisReperfusionPain